HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Opiate Addiction Treatment Claim Comes With $235,000 Price Tag For Sunrise Nutraceuticals

This article was originally published in The Tan Sheet

Executive Summary

The proposed order imposes a nearly $1.4m judgment in consumer redress or asset disgorgement, though all but $235,000 is "suspended based on the defendants’ ability to pay," according to FTC. If the firm and its owner "are later found to have misrepresented their financial condition," the entire amount will be due.

You may also be interested in...



False Weight Loss Claims Land Firm In FTC Complaint, Amazon Could Act Next

In FTC's "first case challenging a marketer’s use of fake paid reviews on an independent retail website," agency files complaint alleging Cure Encapsulations Inc. paid an "amazonverifiedreviews.com" to create and post Amazon reviews of its Quality Encapsulations Garcinia Cambogia Extract with HCA supplement. Emails from the firm to amazonverifiedreviews included, "Please make sure my product should stay a five star.”

Sturman Leads Nature's Bounty For New Owner: Health And Wellness Industry News

Consumer health product industry veteran executive Paul Sturman takes the helm at Nature's Bounty Co. on the day that private equity firm Kohlberg Kravis Roberts & Co. LP closed its acquisition of a controlling interest in the nutritional and health and wellness product manufacturer from Carlyle Group LP. The Ronkonkoma, N.Y.-based firm on Sept. 28 said Sturman has more than 30 years of experience in the sector, including leading Pfizer Inc.'s consumer product group and is a past chairman of the Consumer Healthcare Products Association. (Also see "KKR Steers Nature's Bounty With Carlyle In Back Seat After Seven-Year Ride" - HBW Insight, 24 Jul, 2017.) Sturman succeeds Steve Cahillane, the second CEO Carlyle appointed in 2014 after acquiring Nature's Bounty, then NBTY Inc., in 2010 and taking the firm private. (Also see "Carlyle Group Gives NBTY Helm To Former Coca-Cola Executive Cahillane" - Pink Sheet, 20 Aug, 2014.)

'Withdrawal' Supplement Firm Cut Off: Health And Wellness Industry News

No damages paid in FTC settlement with "Withdrawal Ease" firm; Paleoethics supplements exclusively at Vitamin Shoppe; and tadalafil analog found in six products marketed as supplements.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS108425

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel